• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Mounjaro

Quote

anonymous

Guest
When do you expect to get the indication to treat obesity? I can’t get Wegovy, it’s been 3 months and I can’t start therapy! Mounjaro apoears to have better weight loss anyway. Does Lilly expect to have shortages as well?
 




anonymous said:
When do you expect to get the indication to treat obesity? I can’t get Wegovy, it’s been 3 months and I can’t start therapy! Mounjaro apoears to have better weight loss anyway. Does Lilly expect to have shortages as well?
Click to expand...
What is "better"? Has there been any H2H Phase 3 trials?

Remember, that Actos lowered A1C by 2.6 and Avandia by only 1.9 or something. Different patient populations, and you can't compare across studies. However, you can "buy" the Endocrinologists in your district to parrot the BS out of the marketing team in Indy.

What a garbage industry.
 




Top Bottom
Back
Quote